would like to clarify significant changes in the Group’s operating results are as follows: 1. Revenues from sales and services for the year 2017 decreased 15% compared to the same period of 2016. The main
profit in Q4/2020 and 2020 were THB 127 million and THB 468 million, respectively, decreased by 30% from Q4/2019 and 39% from 2019, corresponding to the decrease in sales. • Gross profit margin in Q4/2020
Baht, decreased by 80% as compared to 3Q2018 in the amount of 872 million Baht which comprising of (1) revenue from Food and Beverages of Dean & DeLuca of 150 million Baht (68% of total revenue
million decreased from Baht 289.69 million in the year 2019 or decreased by 6.03%. Revenue decreased from revenue from Sales Baht 160.41 million, decreased 11.45 million Baht by 6.66%, it effect still from
did not affect the Company’s managements and operations. 2) Announcement of joint venture agreement with Tokyo Tatemono Asia Pte Ltd. (“Tokyo Tatemono”)to jointly develop 2 luxury condominium projects
: Executive Summary The operating results of the second quarter of 2019, for the three-month period ended June 30, 2019 (“Q2 2019”), the Company generated total revenue of 485 million Baht, decreased by 91% as
baht respectively. (2018 : amounting to 58.17 million baht and 168.80 million baht.) The three-months total sale decreased by 8.60 million baht and nine- months total sale decreased by 23.38 million baht
venture agreement with Tokyo Tatemono Asia Pte. Ltd. to jointly develop a luxury condominium project in Thonglor area, Soi Sukhumvit 38. Management outlook and future projects Despite the bearish outlook
and total liabilities stood at THB 6,714.9mn. • Debt to Equity ratio2 equals 1.00 times as of 31 March 2020, decreased from 1.04 times as at end of 2019. Operating result 1Q/2020 Revenue Source of
1,921 million decreased by 7% compared to the previous year. It derived from: • Revenues from sales and services of medical device business for the year 2019 were Baht 1,798 million decreased by 3% in